Statistics for Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease
Total visits
| views | |
|---|---|
| Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease | 181 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| Shiffman_2018_randomised.pdf | 317 |
| java.util.UUID:ab52536d-4668-4e63-8087-a94c4b164753 | 76 |
| java.util.UUID:7b062187-59ba-4ce3-8e14-85b9cbe0d565 | 11 |
| java.util.UUID:fce491b9-315b-4715-aed6-c236b4377b14 | 5 |
Top country views
| views | |
|---|---|
| United States | 124 |
| Germany | 6 |
| United Kingdom | 6 |
| Sweden | 6 |
| Ukraine | 5 |
| China | 4 |
| Canada | 3 |
| France | 1 |
| Malaysia | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 48 |
| Fairfield | 15 |
| Houston | 9 |
| White Plains | 9 |
| Jacksonville | 6 |
| Ann Arbor | 5 |
| Kiev | 5 |
| Stockholm | 5 |
| Kiez | 4 |
| Cambridge | 3 |
| Chicago | 3 |
| San Francisco | 3 |
| Swindon | 3 |
| Toronto | 3 |
| Lake Mary | 2 |
| Shenzhen | 2 |
| Beijing | 1 |
| Bloomsbury | 1 |
| Brooklyn | 1 |
| Gunzenhausen | 1 |
| Malmö | 1 |
| Moscow | 1 |
| Mountain View | 1 |
| Netze | 1 |
| Scottsdale | 1 |
| Seremban | 1 |
| Vendegies-sur-Écaillon | 1 |